美国Helixis www.helixis.com
Helixis公司成立于2007年,由美国加州理工学院生物学家,诺贝尔奖获得者David Baltimore博士和电机工程专家Axel Scherer博士共同创立。总部设在美国的加利福尼亚州。
David Baltimore博士: 世界上最有影响的生物学家之一, 34岁获得麻省理工学院生物学教授,36岁当选美国科学院院士,37岁因为在RNA病毒研究方面的突出贡献获得诺贝尔生理医学奖,自1997‐2006年,担任加州理工学院的院长。
Axel Scherer博士: 世界著名光子与微细加工专家,1993年开办加州理工学院纳米加工研究所,创立了光学晶体学,致力于半导体微加工技术研究,并应用于光子学和生物学设备,在世界光电子领域处于领先地位。2001年合作创办了Luxtera公司,在新一代光子通讯技术方面,具有大量创新性专利,超越了IBM,Intel等公司,是SUN Microsystem (太阳微系统公司),Philips的技术合作伙伴。
2010年Illumina收购Helixis
Helixis, headquartered in Carlsbad, California, develops innovative nucleic acid tools for research and clinical diagnostics applications. The privately held company was founded in 2007 through a unique collaboration between molecular biologists and engineers in the labs of Nobel Laureate David Baltimore, Ph.D., and Axel Scherer, Ph.D., at the California Institute of Technology. Helixis is currently developing a new generation of high-performance, low-cost, real time polymerase chain reaction (qPCR) systems.
At Helixis, we are developing advanced nucleic acid analysis tools for the research scientist and clinical applications. Combining technology from the labs of David Baltimore and Axel Scherer at the California Institute of Technology (Caltech) with insights from life-sciences researchers around the world, we are building next-generation real-time polymerase chain reaction (PCR) solutions that overcome limitations and change the rules.